51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2000030370	2020-03-01	2020-02-29	The efficacy and safety of sirolimusfor the treatment of Systemic Sclerosis: a single-arm, single-ce ...	The efficacy and safety of sirolimusfor the treatment of Systemic Sclerosis: a single-arm, single-ce ...	Systemic Sclerosis	treatment group:sirolimus;	The First Affiliated Hospital of China Medical University	NULL	Recruiting	18		Both	treatment group:20;		China
2	NCT03365869 (ClinicalTrials.gov)	June 1, 2018	4/12/2017	A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis	A Phase ? Pilot-Study With Sirolimus for the Treatment of Systemic Sclerosis	Systemic Sclerosis	Drug: Sirolimus	Peking University People's Hospital	NULL	Not yet recruiting	18 Years	80 Years	All	72	Phase 2	NULL
3	NCT00241189 (ClinicalTrials.gov)	August 2002	14/10/2005	Rapamycin vs Methotrexate in Diffuse SSc	A 48-week, Double-blind, Randomized, Parallel Phase I/II Study of Oral RapamycinVersus Methotrexate ...	Systemic Sclerosis	Drug: rapamycin;Drug: methotrexate	University of California, Los Angeles	NULL	Completed	18 Years	70 Years	Both	17	Phase 1/Phase 2	United States

First Previous1Next Last